Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 21
277
Views
10
CrossRef citations to date
0
Altmetric
Research Articles

Piptolinic acids F–J, five new lanostane-type triterpenoids from Piptoporus betulinus

, , , , , ORCID Icon & ORCID Icon show all
Pages 3044-3051 | Received 16 Jul 2018, Accepted 22 Aug 2018, Published online: 26 Oct 2018
 

Abstract

Five new lanostane-type triterpenoids, named piptolinic acids F − J (15), as well as seven known analogues (612), were isolated from methanolic extract of the fruiting bodies of Piptoporus betulinus. Compounds 14 were 24-methyl-lanostane triterpenoids, while compound 5 was a 3,4-seco-lanostane derivative. Their structures were established on the basis of extensive spectroscopic analysis (1D, 2D NMR, and HRESIMS). Cytotoxicity evaluation indicated that compound 6 exhibited moderate cytotoxic activity against human melanoma cell line A-375 (IC50 = 42.8 μM) and human renal carcinoma cell line 786-O (IC50 = 56.5 μM).

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the National Natural Science Foundation of China (U1703331, 81773998, 21502222), Xinjiang Key Research and Development Program (2016B03038-3), and the Recruitment Program of Global Experts (to Yuan), China.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.